The Food and Drug Administration advisers voted 7-2 that data from Amylyx Pharma warranted approval for their experimental drug to treat Lou Gehrig’s disease.
Health
Health and lifestyle stories from the Portland Press Herald.
Posted inHealth, Nation & World
Monkeypox cases dropping, but racial disparities growing
The number of infections is slowing after hitting a high of 870 cases in a single day on Aug. 22. But the decline has revealed deepening racial divides.
advertisement
Posted inHealth, Nation & World, News
Over 10.5 million children lost a parent or caregiver because of COVID
Little has been done to care for kids orphaned in the pandemic, authors of a global study warn.
Posted inHealth, Maine, News
Rep. Chellie Pingree tests positive for COVID-19
The congresswoman representing Maine’s 1st District says she is experiencing mild symptoms.
Posted inHealth
Got expired COVID tests? Don’t be quick to chuck them.
The U.S. Food and Drug Administration has authorized extended expiration dates for some at-home COVID tests.
Posted inHealth, Nation & World, News
Is COVID-19 winding down? Scientists say no
New booster shots have arrived and social distancing guidelines have eased but COVID-19 infections aren’t going away anytime soon.
Posted inHealth, Maine
A line is drawn between protesters, patients outside Planned Parenthood in Portland
If protesters cross it, a new state law makes them vulnerable to incarceration and fines.
Posted inHealth, Nation & World
Major fall COVID surge unlikely, but variants are a wild card
Infectious disease experts are guardedly optimistic that the reformulated COVID boosters and built-up immunity will prevent a fall surge.
Posted inHealth, Maine, News
New COVID-19 booster shots coming to Maine
Maine is expected to receive 80,500 doses of new omicron-targeting booster shots within the next 2 weeks.
Posted inHealth, Nation & World, News
U.S. advisers endorse updated COVID-19 shots for fall boosters
The original vaccines still offer strong protection against severe illness and death, especially among younger and healthier people, but those vaccines were designed to target the virus strain that circulated in early 2020.